A novel anti-rheumatic drug suppresses tumor necrosis factor-alpha and augments interleukin-10 in adjuvant arthritic rats (Q73275991)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

A novel anti-rheumatic drug suppresses tumor necrosis factor-alpha and augments interleukin-10 in adjuvant arthritic rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Hisadome M

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Fukuda T

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sumichika H

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Hanano T

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Adachi K

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

409

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

331-335

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

Anti-arthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNFα processing

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900866-9

Role of cytokines in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900866-9

A novel dual regulator of tumor necrosis factor-alpha and interleukin-10 protects mice from endotoxin-induced shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900866-9

Cellular adhesion molecules in rat adjuvant arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900866-9

Novel DMARDs on the basis of a new concept of dual cytokine regulation, TNF-alpha suppression and IL-10 augmentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900866-9

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900866-9

Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900866-9

Therapeutic potential and strategies for inhibiting tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900866-9

Elevated levels of TNF in the joints of adjuvant arthritic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900866-9

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900866-9

Interleukin-10 inhibition of the progression of established collagen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900866-9

Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900866-9

10.1016/S0014-2999(00)00866-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108829%20AND%20SRC:MED&resulttype=core&format=json